Literature DB >> 21396487

Hemoglobin-ligand binding: understanding Hb function and allostery on atomic level.

Martin K Safo1, Mostafa H Ahmed, Mohini S Ghatge, Telih Boyiri.   

Abstract

The major physiological function of hemoglobin (Hb) is to bind oxygen in the lungs and deliver it to the tissues. This function is regulated and/or made efficient by endogenous heterotropic effectors. A number of synthetic molecules also bind to Hb to alter its allosteric activity. Our purpose is to review the current state of Hb structure and function that involves ensemble of tense and relaxed hemoglobin states and the dynamic equilibrium of the multistate due to the binding of endogenous heterotropic or synthetic allosteric effectors. The review also discusses the atomic interactions of synthetic ligands with the function or altered allosteric function of Hb that could be potentially harnessed for the treatment of diseases. This article is part of a Special Issue entitled: Protein Structure and Function in the Crystalline State. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396487     DOI: 10.1016/j.bbapap.2011.02.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  30 in total

1.  Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease.

Authors:  Piyusha P Pagare; Mohini S Ghatge; Faik N Musayev; Tanvi M Deshpande; Qiukan Chen; Courtney Braxton; Solyi Kim; Jürgen Venitz; Yan Zhang; Osheiza Abdulmalik; Martin K Safo
Journal:  Bioorg Med Chem       Date:  2018-04-06       Impact factor: 3.641

2.  Crystallographic characterization of the nitric oxide derivative of R-state human hemoglobin.

Authors:  Jun Yi; Alexei S Soares; George B Richter-Addo
Journal:  Nitric Oxide       Date:  2014-04-22       Impact factor: 4.427

3.  Structures and oxygen affinities of crystalline human hemoglobin C (β6 Glu->Lys) in the R and R2 quaternary structures.

Authors:  Naoya Shibayama; Kanako Sugiyama; Sam-Yong Park
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

4.  Rational modification of vanillin derivatives to stereospecifically destabilize sickle hemoglobin polymer formation.

Authors:  Tanvi M Deshpande; Piyusha P Pagare; Mohini S Ghatge; Qiukan Chen; Faik N Musayev; Jurgen Venitz; Yan Zhang; Osheiza Abdulmalik; Martin K Safo
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-10-02       Impact factor: 7.652

5.  Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents.

Authors:  A M Omar; M A Mahran; M S Ghatge; N Chowdhury; F H A Bamane; M E El-Araby; O Abdulmalik; M K Safo
Journal:  Org Biomol Chem       Date:  2015-06-14       Impact factor: 3.876

6.  An Investigation of Structure-Activity Relationships of Azolylacryloyl Derivatives Yielded Potent and Long-Acting Hemoglobin Modulators for Reversing Erythrocyte Sickling.

Authors:  Abdelsattar M Omar; Osheiza Abdulmalik; Mohini S Ghatge; Yosra A Muhammad; Steven D Paredes; Moustafa E El-Araby; Martin K Safo
Journal:  Biomolecules       Date:  2020-11-02

7.  Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin.

Authors:  Osheiza Abdulmalik; Mohini S Ghatge; Faik N Musayev; Apurvasena Parikh; Qiukan Chen; Jisheng Yang; Ijeoma Nnamani; Richmond Danso-Danquah; Dorothy N Eseonu; Toshio Asakura; Donald J Abraham; Jurgen Venitz; Martin K Safo
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-10-19

Review 8.  Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.

Authors:  Martin K Safo; Gregory J Kato
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-21       Impact factor: 3.722

9.  Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell Disease.

Authors:  Guoyan G Xu; Piyusha P Pagare; Mohini S Ghatge; Ronni P Safo; Aheema Gazi; Qiukan Chen; Tanya David; Alhumaidi B Alabbas; Faik N Musayev; Jürgen Venitz; Yan Zhang; Martin K Safo; Osheiza Abdulmalik
Journal:  Mol Pharm       Date:  2017-09-13       Impact factor: 4.939

Review 10.  New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?

Authors:  Esther Oder; Martin K Safo; Osheiza Abdulmalik; Gregory J Kato
Journal:  Br J Haematol       Date:  2016-09-08       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.